Exclusive

Publication

Byline

$15 M injection in NTU Singapore to leverage AI in medical education and research

Singapore, May 16 -- The Sim Foundation has pledged a gift of S$15 million to Nanyang Technological University, Singapore (NTU Singapore), which will bolster the University's efforts in delivering tra... Read More


Collaboration to accelerate genomics innovation in Japan

Singapore, May 16 -- US-based Illumina, a global leader in DNA sequencing and array-based technologies, and the Okinawa Institute of Science and Technology (OIST), an international graduate university... Read More


China's Viva Biotech launches new AI-driven drug discovery platform

Singapore, May 16 -- China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensiveAI-Driven Drug Discovery (AIDD) plat... Read More


US manufactures world's first mRNA-based personalised CRISPR therapy

Singapore, May 16 -- Aldevron, a global leader in the production of DNA, RNA and protein, together withIntegrated DNA Technologies(IDT), a global leader in genomics solutions, have announced the succe... Read More


Korean startup Rznomics partners with Eli Lilly to commercialise RNA-editing therapeutics

Singapore, May 16 -- Rznomics Inc., aSouth Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered into a strategic global research collaboration and licensing agreem... Read More


Targeting inflammation at the source: VX-01 aims to redefine NPDR treatment with first oral therapy

Singapore, May 16 -- Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap-one that often leaves them untreated until their condition worsens and requires invasi... Read More


Curaleaf International launches range of medical cannabis products in Australia

Singapore, May 15 -- American firm Curaleaf International, part of Curaleaf Holdings, Inc., has announced the launch of Curaleaf branded products inAustralia. This announcement marks the expansion of ... Read More


Terumo takes over WuXi Biologics' drug product plant in Germany for EUR 150 million

Singapore, May 15 -- China-based WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has entered into an agreement with Terumo Corporation that Teru... Read More


TriLink BioTechnologies and International Vaccine Institute ink MoU to support development of mRNA-based vaccines

Singapore, May 15 -- US-basedTriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, and South Korea-based International Vaccine Institute (I... Read More


Agilent partners with Ubix Therapeutics to advance transformative cancer research in South Korea

Singapore, May 15 -- Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Kore... Read More